This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kawano, Y. Articles by Omae, T. Search for Related Content PubMed PubMed Citation Articles by Kawano, Y. Articles by Omae, T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB MAGNESIUM COMPOUNDS MAGNESIUM, ELEMENTAL

(Hypertension. 1998;32:260-265.)
© 1998 American Heart Association, Inc.

Scientific Contributions

Effects of Magnesium Supplementation in Hypertensive Patients

Assessment by Office, Home, and Ambulatory Blood Pressures

Yuhei Kawano; Hiroaki Matsuoka; Shuichi Takishita; ; Teruo Omae

From the Division of Hypertension and Nephrology, National Cardiovascular Center, Suita, Osaka, Japan.

Correspondence to Yuhei Kawano, MD, Division of Hypertension and Nephrology, National Cardiovascular Center, 5–7-1 Fujishirodai, Suita, Osaka 565-8565, Japan. E-mail ykawano{at}hsp.ncvc.go.jp

Abstract—An increase in magnesium intake has been suggested to lower blood pressure (BP). However, the results of clinical studies are inconsistent. We studied the effects of magnesium supplementation on office, home, and ambulatory BPs in patients with essential hypertension. Sixty untreated or treated patients (34 men and 26 women, aged 33 to 74 years) with office BP >140/90 mm Hg were assigned to an 8-week magnesium supplementation period or an 8-week control period in a randomized crossover design. The subjects were given 20 mmol/d magnesium in the form of magnesium oxide during the intervention period. In the control period, office, home, and average 24-hour BPs (mean±SE) were 148.6±1.6/90.0±0.9, 136.4±1.3/86.8±0.9, and 133.7±1.3/81.0±0.8 mm Hg, respectively. All of these BPs were significantly lower in the magnesium supplementation period than in the control period, although the differences were small (office, 3.7±1.3/1.7±0.7 mm Hg; home, 2.0±0.8/1.4±0.6 mm Hg; 24-hour, 2.5±1.0/1.4±0.6 mm Hg). Serum concentration and urinary excretion of magnesium increased significantly with magnesium supplementation. Changes in 24-hour systolic and diastolic BPs were correlated negatively with baseline BP or changes in serum magnesium concentration. These results indicate that magnesium supplementation lowers BP in hypertensive subjects and this effect is greater in subjects with higher BP. Our study supports the usefulness of increasing magnesium intake as a lifestyle modification in the management of hypertension, although its antihypertensive effect may be small.

Key Words: hypertension, essential • magnesium • nonpharmacological treatment • blood pressure • blood pressure, ambulatory

This article has been cited by other articles:

				L. R Harriss, D. R English, J. Powles, G. G Giles, A. M Tonkin, A. M Hodge, L. Brazionis, and K. O'Dea Dietary patterns and cardiovascular mortality in the Melbourne Collaborative Cohort Study Am. J. Clinical Nutrition, July 1, 2007; 86(1): 221 - 229. [Abstract] [Full Text] [PDF]

				T. Kato, T. Horio, M. Tomiyama, K. Kamide, S. Nakamura, F. Yoshihara, H. Nakata, H. Nakahama, and Y. Kawano Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients Nephrol. Dial. Transplant., March 1, 2007; 22(3): 911 - 916. [Abstract] [Full Text] [PDF]

				K. Aihara, O. Kajimoto, H. Hirata, R. Takahashi, and Y. Nakamura Effect of Powdered Fermented Milk with Lactobacillus helveticus on Subjects with High-Normal Blood Pressure or Mild Hypertension J. Am. Coll. Nutr., August 1, 2005; 24(4): 257 - 265. [Abstract] [Full Text] [PDF]

				T. Shimosawa, K. Takano, K. Ando, and T. Fujita Magnesium Inhibits Norepinephrine Release by Blocking N-Type Calcium Channels at Peripheral Sympathetic Nerve Endings Hypertension, December 1, 2004; 44(6): 897 - 902. [Abstract] [Full Text] [PDF]

				M. S. Farvid, M. Jalali, F. Siassi, N. Saadat, and M. Hosseini The Impact of Vitamins and/or Mineral Supplementation on Blood Pressure in Type 2 Diabetes J. Am. Coll. Nutr., June 1, 2004; 23(3): 272 - 279. [Abstract] [Full Text] [PDF]

				A. Arnon, J. M. Hamlyn, and M. P. Blaustein Na+ entry via store-operated channels modulates Ca2+ signaling in arterial myocytes Am J Physiol Cell Physiol, January 1, 2000; 278(1): C163 - C173. [Abstract] [Full Text] [PDF]